Alnylam Pharmaceuticals
ALNY
#582
Rank
โ‚ฌ31.72 B
Marketcap
245,13ย โ‚ฌ
Share price
-1.34%
Change (1 day)
72.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company